Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our people
    • Careers at PHARMAC
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in Review 2018/2019
    • Strategies
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • Feedback on managing fairer access to hospital medical devices
    • What's happening in each category?
    • About our role in device management
    • Device Advice
  • News (current)
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
    • One Heart Many Lives
  • Pacific
    • Pacific
    • Pacific responsiveness strategy 2017-2026
    • Stage one: Pacific Responsiveness Strategy
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences for prescription pharmaceuticals
  • Information for…

News

  • Media releases
  • Notifications
  • Consultations
  • Tenders
  • RFPs
  • OIA responses

News

Notifications

Changes to the National Immunisation Schedule

10/03/2014

PHARMAC is pleased to announce further decisions related to the National Immunisation Schedule (NIS) that will take effect from 1 July 2014.

Notifications

Decision to award sole supply to Tacrolimus Sandoz

07/03/2014

PHARMAC has decided to award Tacrolimus Sandoz capsules Sole Subsidised Supply status in the community, and Hospital Supply Status in DHB hospitals.

Notifications

February 2014 tender notification

28/02/2014

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the Invitation to Tender, dated 07 November 2013.

RFPs

RFP - Supply of erythropoietin

28/02/2014

PHARMAC invites proposals for the supply of erythropoietin in New Zealand. Closes: 1 April 2014.

Notifications

Agreement with Smith & Nephew Limited for the Supply of Wound Care Products

26/02/2014

PHARMAC is pleased to announce the approval of an agreement with Smith & Nephew Limited (“Smith & Nephew”) for the supply of wound care products.  

Media releases

PHARMAC seeking public views on proposed new decision criteria

25/02/2014

PHARMAC is asking for people’s views on a proposed new framework for making pharmaceutical funding decisions.

Consultations

Proposal to list a range of Wound Care products supplied by 3M New Zealand Limited

24/02/2014

PHARMAC is seeking feedback on a proposal to list a range of wound care products supplied by 3M New Zealand Limited (“3M”) in Part III of Section H of the Pharmaceutical Schedule from 1 April 2014. Closes: Wednesday, 12 March 2014.

Notifications

Widening of funding restrictions for rituximab and eltrombopag

20/02/2014

PHARMAC is pleased to announce the approval of proposals to widen the restriction on rituximab use in DHB hospitals and expand the funding of eltrombopag in both hospitals and the community.

Consultations

Decision criteria consultation – proposal for change

18/02/2014

PHARMAC is seeking feedback on the criteria it uses to make decisions. You can have your say on our proposed changes to the decision criteria. Closes: 5 pm, Monday, 21 April 2014.

Media releases

Applications sought for Consumer Advisory Committee

18/02/2014

PHARMAC is seeking three new people for its Consumer Advisory Committee.

RFPs

RFP - Supply of national vaccine purchasing, storage and distribution services

14/02/2014

PHARMAC invites proposals for the supply of national vaccine purchasing, storage and distribution services to PHARMAC.

Consultations

Proposal for paliperidone depot injection, risperidone depot injection and olanzapine depot injection

13/02/2014

PHARMAC is seeking feedback on a proposal to fund paliperidone depot injection (Invega Sustenna) from 1 May 2014 in conjunction with a price decrease on risperidone depot injection (Risperdal Consta), both through a provisional agreement with Janssen-Cilag Pty Ltd (Janssen). Closes 5 pm, Friday, 28 February 2014.

Consultations

Proposal for sole supply of nicotine replacement therapy (NRT)

13/02/2014

PHARMAC is seeking feedback on a proposal to enter into a new sole supply arrangement with Novartis Consumer for Habitrol, the currently funded brand of nicotine lozenges, patches and gum (nicotine replacement therapy; NRT). Closes 5 pm, Friday, 28 February 2014. 

Media releases

PHARMAC tender reveals vibrant market for pharmaceuticals

12/02/2014

The number of companies bidding to be suppliers through the PHARMAC tender has grown to its largest size ever.

Notifications

Progressing to a request for proposals for the supply and distribution of compression hosiery for the treatment of venous leg ulcers

04/02/2014

PHARMAC would like to notify suppliers, DHBs, service providers and treating clinicians that PHARMAC’s interest in this area is now expected to be progressed further via a request for proposals (RFP) for the supply and distribution of compression hosiery for the treatment of venous leg ulcers (VLU).

Notifications

January 2014 tender notification

30/01/2014

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012.

Notifications

Captopril tablets discontinued – transition advice to another ACE inhibitor

30/01/2014

A recall has been issued for stock of the currently funded captopril tablets, 12.5 mg, 25 mg, and 50 mg m-Captopril tablets. PHARMAC has been unable to secure a continued, long-term supply of captopril tablets so captopril tablets will no longer be funded via the Pharmaceutical Schedule. We recommend that prescribers transition their patients to another funded alternative.

Consultations

Proposal for sole supply of tacrolimus

30/01/2014

PHARMAC is seeking feedback on a proposal to list Tacrolimus Sandoz in the Pharmaceutical Schedule, and to award Sole Subsidised Supply Status (the only funded brand in the community) and Hospital Supply Status (the only available brand in DHB hospitals, subject to a 1% discretionary variance limit) to Tacrolimus Sandoz. Closes: Friday, 14 February 2014.

Consultations

Request for information on the potential listing of a range of medicines

30/01/2014

PHARMAC is interested in receiving information from suppliers and other interested parties relating to the supply of a range of medicines that are not currently registered with Medsafe in New Zealand. Closes: 5 pm, Friday, 7 March 2014.

Notifications

Approval of agreement for Applied Medical New Zealand Limited supply of disposable laparoscopic medical devices

27/01/2014

PHARMAC is pleased to announce the approval of an agreement with Applied Medical New Zealand Ltd (Applied Medical) for the supply of a selection of disposable laparoscopic devices. 

  • 1
  • ...
  • 53
  • 54
  • 55
  • 56
  • 57
  • ...
  • 64

Newsletters

Make our website better – take a short survey

Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.


 PHARMACnz Twitter    PHARMACnz Facebook    PHARMAC in LinkedIn


Media queries

For media queries, contact:

021 863 342

media@pharmac.govt.nz

Media phone is monitored 9am–5pm weekdays

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • Website changes
  • About this site

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed
  • Subscribe

Back to top

New Zealand Government